Clinical Trial Update: Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial [Phase 4]

View source ↗

Summary

A multicenter, randomized, open-label, crossover Phase 4 trial evaluating sequencing and combination of mirabegron and TTNS for overactive bladder syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Mirabegron (mirabegron)
• TTNS (transcutaneous tibial nerve stimulation)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Overactive Bladder Syndrome | Phase 4 | Status: UNKNOWN